Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Guatemala | 48 | 2024 | 142 | 6.270 |
Why?
|
Rural Population | 27 | 2023 | 2210 | 3.580 |
Why?
|
Midwifery | 7 | 2021 | 132 | 2.970 |
Why?
|
Maternal Health Services | 7 | 2021 | 455 | 2.830 |
Why?
|
Health Services, Indigenous | 6 | 2021 | 42 | 2.460 |
Why?
|
Child Nutrition Disorders | 4 | 2021 | 149 | 1.960 |
Why?
|
Growth Disorders | 6 | 2023 | 645 | 1.540 |
Why?
|
Delivery, Obstetric | 4 | 2021 | 906 | 1.380 |
Why?
|
Trypanosoma cruzi | 10 | 2011 | 198 | 1.280 |
Why?
|
Home Childbirth | 2 | 2019 | 51 | 1.270 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2024 | 11725 | 1.240 |
Why?
|
Gardening | 2 | 2022 | 19 | 1.040 |
Why?
|
Malnutrition | 2 | 2021 | 625 | 0.980 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2022 | 2020 | 0.900 |
Why?
|
Growth and Development | 1 | 2023 | 52 | 0.890 |
Why?
|
Diabetes Mellitus | 6 | 2023 | 5751 | 0.860 |
Why?
|
Rural Health Services | 3 | 2021 | 379 | 0.850 |
Why?
|
Nutritional Status | 2 | 2023 | 1609 | 0.840 |
Why?
|
Water-Electrolyte Balance | 5 | 2007 | 346 | 0.840 |
Why?
|
Language | 2 | 2023 | 1471 | 0.800 |
Why?
|
Quality Improvement | 4 | 2021 | 3749 | 0.770 |
Why?
|
Hospitals, Maternity | 1 | 2019 | 42 | 0.700 |
Why?
|
Contraceptive Agents | 2 | 2022 | 151 | 0.680 |
Why?
|
Child Development | 4 | 2023 | 2223 | 0.670 |
Why?
|
Preconception Care | 1 | 2019 | 134 | 0.630 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3336 | 0.620 |
Why?
|
Myxedema | 1 | 2017 | 17 | 0.600 |
Why?
|
Rural Health | 3 | 2017 | 305 | 0.600 |
Why?
|
Achondroplasia | 1 | 2017 | 26 | 0.590 |
Why?
|
Family Planning Services | 2 | 2018 | 263 | 0.590 |
Why?
|
Hyperargininemia | 1 | 2016 | 12 | 0.580 |
Why?
|
Delayed Diagnosis | 2 | 2017 | 441 | 0.580 |
Why?
|
Maternal Mortality | 4 | 2021 | 310 | 0.570 |
Why?
|
Developing Countries | 10 | 2023 | 2815 | 0.570 |
Why?
|
Pregnancy in Adolescence | 1 | 2018 | 158 | 0.560 |
Why?
|
Perinatal Care | 1 | 2018 | 227 | 0.550 |
Why?
|
Organelles | 4 | 2011 | 264 | 0.540 |
Why?
|
Minority Groups | 1 | 2023 | 1223 | 0.540 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2019 | 378 | 0.540 |
Why?
|
Vacuoles | 5 | 2011 | 230 | 0.530 |
Why?
|
Urban Population | 2 | 2023 | 2021 | 0.530 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 127 | 0.530 |
Why?
|
Propranolol | 1 | 2017 | 502 | 0.520 |
Why?
|
Human Rights | 1 | 2018 | 307 | 0.520 |
Why?
|
Health Education | 3 | 2020 | 1056 | 0.510 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2021 | 347 | 0.510 |
Why?
|
Fetal Monitoring | 3 | 2020 | 70 | 0.500 |
Why?
|
Communication Barriers | 1 | 2018 | 398 | 0.500 |
Why?
|
Toxoplasma | 3 | 2011 | 150 | 0.490 |
Why?
|
Pharmacists | 1 | 2017 | 248 | 0.490 |
Why?
|
Feeding Methods | 1 | 2014 | 35 | 0.490 |
Why?
|
Qualitative Research | 6 | 2023 | 2682 | 0.490 |
Why?
|
Contraception Behavior | 1 | 2016 | 185 | 0.480 |
Why?
|
Schools | 2 | 2021 | 1433 | 0.480 |
Why?
|
Refugees | 1 | 2021 | 511 | 0.480 |
Why?
|
Continuity of Patient Care | 2 | 2018 | 1049 | 0.470 |
Why?
|
Albuminuria | 1 | 2018 | 682 | 0.470 |
Why?
|
Problem Solving | 1 | 2016 | 440 | 0.460 |
Why?
|
Diet | 6 | 2023 | 7939 | 0.450 |
Why?
|
Polyphosphates | 6 | 2011 | 18 | 0.450 |
Why?
|
Nurse Midwives | 1 | 2013 | 24 | 0.450 |
Why?
|
Community Health Services | 2 | 2017 | 650 | 0.440 |
Why?
|
Humans | 78 | 2024 | 744343 | 0.440 |
Why?
|
Family | 2 | 2021 | 3147 | 0.440 |
Why?
|
Vasodilator Agents | 1 | 2017 | 977 | 0.430 |
Why?
|
Contraception | 1 | 2016 | 359 | 0.430 |
Why?
|
Employment | 1 | 2019 | 1132 | 0.430 |
Why?
|
Social Perception | 1 | 2016 | 425 | 0.430 |
Why?
|
Hemangioma | 1 | 2017 | 738 | 0.410 |
Why?
|
Drugs, Generic | 1 | 2017 | 421 | 0.410 |
Why?
|
Middle East | 2 | 2023 | 219 | 0.400 |
Why?
|
Telemedicine | 3 | 2020 | 2872 | 0.400 |
Why?
|
Female | 47 | 2023 | 380194 | 0.400 |
Why?
|
Paternal Behavior | 1 | 2011 | 32 | 0.400 |
Why?
|
Face | 1 | 2017 | 994 | 0.390 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.380 |
Why?
|
Needs Assessment | 2 | 2017 | 1147 | 0.380 |
Why?
|
Infant Food | 1 | 2011 | 141 | 0.380 |
Why?
|
Pregnancy | 13 | 2023 | 29144 | 0.370 |
Why?
|
Failure to Thrive | 1 | 2011 | 136 | 0.370 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2020 | 2208 | 0.370 |
Why?
|
Mass Screening | 2 | 2018 | 5255 | 0.370 |
Why?
|
Protozoan Proteins | 8 | 2011 | 827 | 0.370 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.370 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2278 | 0.360 |
Why?
|
Nutrition Therapy | 2 | 2021 | 96 | 0.360 |
Why?
|
Professional Role | 1 | 2013 | 306 | 0.360 |
Why?
|
Indians, Central American | 3 | 2021 | 15 | 0.350 |
Why?
|
Poverty | 3 | 2021 | 2660 | 0.340 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15165 | 0.340 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.320 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1956 | 0.310 |
Why?
|
Quality-Adjusted Life Years | 3 | 2023 | 1683 | 0.310 |
Why?
|
Referral and Consultation | 2 | 2021 | 3528 | 0.300 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5137 | 0.290 |
Why?
|
Calcium | 6 | 2011 | 5756 | 0.290 |
Why?
|
Feeding Behavior | 1 | 2019 | 3188 | 0.290 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.290 |
Why?
|
Protons | 3 | 2011 | 1127 | 0.290 |
Why?
|
Breast Feeding | 2 | 2014 | 1338 | 0.290 |
Why?
|
Adult | 23 | 2023 | 214055 | 0.280 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2006 | 205 | 0.270 |
Why?
|
Infant | 12 | 2024 | 35136 | 0.260 |
Why?
|
Cultural Characteristics | 2 | 2017 | 262 | 0.260 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 25043 | 0.260 |
Why?
|
Child, Preschool | 8 | 2023 | 41006 | 0.250 |
Why?
|
Tuberculosis | 1 | 2017 | 1912 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3022 | 0.240 |
Why?
|
Asia | 2 | 2023 | 610 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2014 | 3923 | 0.240 |
Why?
|
Trypanosoma brucei brucei | 3 | 2011 | 43 | 0.230 |
Why?
|
Oceania | 1 | 2023 | 17 | 0.230 |
Why?
|
Aflatoxins | 1 | 2023 | 10 | 0.230 |
Why?
|
Risk Factors | 8 | 2023 | 72290 | 0.230 |
Why?
|
Osmotic Pressure | 4 | 2010 | 151 | 0.220 |
Why?
|
Acceleration | 1 | 2024 | 181 | 0.220 |
Why?
|
Africa, Northern | 1 | 2023 | 82 | 0.220 |
Why?
|
Cytosol | 1 | 2006 | 901 | 0.220 |
Why?
|
Infant, Newborn | 7 | 2023 | 25625 | 0.220 |
Why?
|
Software | 2 | 2019 | 4443 | 0.220 |
Why?
|
Prevalence | 5 | 2023 | 15226 | 0.220 |
Why?
|
Monitoring, Physiologic | 2 | 2020 | 1738 | 0.210 |
Why?
|
Male | 23 | 2023 | 350118 | 0.200 |
Why?
|
Family Characteristics | 2 | 2020 | 1000 | 0.200 |
Why?
|
Early Detection of Cancer | 4 | 2022 | 3086 | 0.200 |
Why?
|
Jordan | 1 | 2021 | 74 | 0.200 |
Why?
|
Primary Health Care | 1 | 2018 | 4558 | 0.200 |
Why?
|
Child | 10 | 2023 | 77709 | 0.190 |
Why?
|
Pilot Projects | 5 | 2024 | 8324 | 0.190 |
Why?
|
Body Weight | 2 | 2023 | 4669 | 0.190 |
Why?
|
Young Adult | 8 | 2023 | 56430 | 0.190 |
Why?
|
Aquaporins | 3 | 2007 | 174 | 0.190 |
Why?
|
Socioeconomic Factors | 3 | 2023 | 7785 | 0.180 |
Why?
|
Infant, Small for Gestational Age | 1 | 2023 | 440 | 0.180 |
Why?
|
Cities | 1 | 2022 | 513 | 0.180 |
Why?
|
Africa South of the Sahara | 1 | 2023 | 724 | 0.180 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 3843 | 0.180 |
Why?
|
Community Health Planning | 1 | 2020 | 165 | 0.180 |
Why?
|
Eggs | 1 | 2021 | 184 | 0.180 |
Why?
|
Hospitals, Special | 1 | 2020 | 101 | 0.170 |
Why?
|
Fetal Growth Retardation | 1 | 2023 | 570 | 0.170 |
Why?
|
Heart Rate, Fetal | 1 | 2019 | 75 | 0.170 |
Why?
|
Leg | 1 | 2024 | 1116 | 0.160 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 2018 | 29 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.160 |
Why?
|
Geographic Information Systems | 1 | 2020 | 281 | 0.160 |
Why?
|
Orthotic Devices | 1 | 2019 | 128 | 0.160 |
Why?
|
Food, Fortified | 2 | 2021 | 191 | 0.160 |
Why?
|
Aged | 12 | 2023 | 163280 | 0.150 |
Why?
|
Maternal Welfare | 1 | 2018 | 115 | 0.150 |
Why?
|
Editorial Policies | 1 | 2022 | 451 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
Motor Skills | 1 | 2021 | 522 | 0.150 |
Why?
|
Adolescent | 8 | 2023 | 85781 | 0.150 |
Why?
|
Women's Rights | 1 | 2017 | 69 | 0.150 |
Why?
|
Labor, Obstetric | 1 | 2020 | 333 | 0.150 |
Why?
|
Antibiotics, Antitubercular | 1 | 2017 | 104 | 0.150 |
Why?
|
Population Groups | 1 | 2018 | 209 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1530 | 0.140 |
Why?
|
Family Planning Policy | 1 | 2016 | 7 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 458 | 0.140 |
Why?
|
Neurocutaneous Syndromes | 1 | 2017 | 51 | 0.140 |
Why?
|
Proton Pumps | 3 | 2011 | 30 | 0.140 |
Why?
|
Amino Acids | 1 | 2003 | 1736 | 0.140 |
Why?
|
Disabled Children | 1 | 2019 | 247 | 0.140 |
Why?
|
Life Expectancy | 1 | 2023 | 1184 | 0.140 |
Why?
|
Health Care Rationing | 1 | 2020 | 437 | 0.140 |
Why?
|
Neoplasms | 2 | 2022 | 21683 | 0.140 |
Why?
|
Body Height | 1 | 2023 | 1577 | 0.140 |
Why?
|
Health Policy | 2 | 2020 | 2661 | 0.140 |
Why?
|
Allied Health Personnel | 1 | 2017 | 162 | 0.140 |
Why?
|
Neck Pain | 1 | 2017 | 180 | 0.140 |
Why?
|
Drugs, Essential | 1 | 2017 | 73 | 0.140 |
Why?
|
House Calls | 1 | 2017 | 160 | 0.130 |
Why?
|
Rifampin | 1 | 2017 | 315 | 0.130 |
Why?
|
Middle Aged | 12 | 2023 | 213383 | 0.130 |
Why?
|
Water | 1 | 2022 | 1395 | 0.130 |
Why?
|
Pharmaceutical Services | 1 | 2017 | 140 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.130 |
Why?
|
Pharmacies | 1 | 2017 | 150 | 0.130 |
Why?
|
India | 1 | 2021 | 2197 | 0.130 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.130 |
Why?
|
Quality of Health Care | 3 | 2020 | 4371 | 0.130 |
Why?
|
Aortic Coarctation | 1 | 2017 | 281 | 0.130 |
Why?
|
Eye Abnormalities | 1 | 2017 | 246 | 0.120 |
Why?
|
Acetic Acid | 1 | 2014 | 55 | 0.120 |
Why?
|
Health Surveys | 2 | 2022 | 4037 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1124 | 0.120 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2017 | 434 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2020 | 5078 | 0.120 |
Why?
|
Perception | 2 | 2020 | 1198 | 0.120 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.120 |
Why?
|
Research Design | 2 | 2023 | 5987 | 0.120 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2170 | 0.120 |
Why?
|
Prenatal Care | 1 | 2021 | 1092 | 0.120 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.120 |
Why?
|
Scapula | 1 | 2014 | 164 | 0.110 |
Why?
|
Prejudice | 1 | 2017 | 570 | 0.110 |
Why?
|
Thyroxine | 1 | 2017 | 667 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2006 | 2557 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1316 | 0.110 |
Why?
|
Malpractice | 1 | 2017 | 572 | 0.110 |
Why?
|
Subcellular Fractions | 2 | 2011 | 547 | 0.110 |
Why?
|
Fever | 2 | 2017 | 1616 | 0.110 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 737 | 0.100 |
Why?
|
Vacuolar Proton-Translocating ATPases | 3 | 2011 | 195 | 0.100 |
Why?
|
Cyclic AMP | 2 | 2007 | 1472 | 0.100 |
Why?
|
Babesiosis | 1 | 2013 | 92 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2069 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.100 |
Why?
|
Calcium Chloride | 1 | 2011 | 77 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3282 | 0.100 |
Why?
|
Nutritive Value | 1 | 2014 | 339 | 0.100 |
Why?
|
Medical Audit | 1 | 2012 | 467 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2019 | 1534 | 0.100 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 124 | 0.100 |
Why?
|
Program Evaluation | 1 | 2019 | 2488 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1442 | 0.090 |
Why?
|
Culture | 1 | 2014 | 633 | 0.090 |
Why?
|
Acid Anhydride Hydrolases | 2 | 2007 | 72 | 0.090 |
Why?
|
Ion Transport | 1 | 2011 | 320 | 0.090 |
Why?
|
Contractile Proteins | 1 | 2011 | 246 | 0.090 |
Why?
|
Health Behavior | 1 | 2021 | 2636 | 0.090 |
Why?
|
Food | 1 | 2014 | 771 | 0.090 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 590 | 0.080 |
Why?
|
Drug Costs | 1 | 2017 | 1105 | 0.080 |
Why?
|
Maternal Behavior | 1 | 2011 | 311 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2011 | 625 | 0.080 |
Why?
|
Food Supply | 1 | 2014 | 524 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1681 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 950 | 0.080 |
Why?
|
Education | 1 | 2011 | 543 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9959 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3835 | 0.080 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2014 | 975 | 0.070 |
Why?
|
Heart | 1 | 2020 | 4467 | 0.070 |
Why?
|
Microbodies | 1 | 2006 | 36 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2016 | 5319 | 0.070 |
Why?
|
Lyme Disease | 1 | 2013 | 621 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3255 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3297 | 0.070 |
Why?
|
Interprofessional Relations | 1 | 2013 | 1011 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.070 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2006 | 89 | 0.070 |
Why?
|
Microscopy, Electron | 3 | 2004 | 2645 | 0.070 |
Why?
|
Focus Groups | 1 | 2011 | 1321 | 0.070 |
Why?
|
Cytokinesis | 1 | 2007 | 177 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1797 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2014 | 1153 | 0.070 |
Why?
|
Medication Adherence | 1 | 2017 | 2063 | 0.070 |
Why?
|
Protein Prenylation | 1 | 2005 | 73 | 0.070 |
Why?
|
Proton-Translocating ATPases | 1 | 2005 | 116 | 0.070 |
Why?
|
Trypanosomatina | 1 | 2005 | 2 | 0.070 |
Why?
|
Smoking | 1 | 2022 | 8987 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2538 | 0.060 |
Why?
|
Endocytosis | 2 | 2010 | 985 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12720 | 0.060 |
Why?
|
Silver Nitrate | 1 | 2004 | 12 | 0.060 |
Why?
|
Mercuric Chloride | 1 | 2004 | 16 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 1119 | 0.060 |
Why?
|
Fibrinolysis | 1 | 2006 | 322 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2025 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1660 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12959 | 0.060 |
Why?
|
Calcium-Transporting ATPases | 1 | 2004 | 123 | 0.060 |
Why?
|
Pyrophosphatases | 1 | 2004 | 137 | 0.060 |
Why?
|
Aflatoxin B1 | 1 | 2023 | 18 | 0.060 |
Why?
|
Blood Coagulation Factors | 1 | 2006 | 355 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 473 | 0.060 |
Why?
|
Zinc | 1 | 2007 | 684 | 0.060 |
Why?
|
Risk Assessment | 2 | 2022 | 23338 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3772 | 0.060 |
Why?
|
Cloning, Molecular | 5 | 2007 | 4320 | 0.060 |
Why?
|
Social Support | 1 | 2012 | 2118 | 0.050 |
Why?
|
Zea mays | 1 | 2023 | 105 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3218 | 0.050 |
Why?
|
Bioreactors | 1 | 2023 | 236 | 0.050 |
Why?
|
Sanitation | 1 | 2021 | 93 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13284 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 643 | 0.050 |
Why?
|
Developed Countries | 1 | 2023 | 437 | 0.050 |
Why?
|
Animals | 14 | 2011 | 168757 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2017 | 63114 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1312 | 0.050 |
Why?
|
Medical Assistance | 1 | 2020 | 104 | 0.050 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39050 | 0.050 |
Why?
|
Blood Coagulation | 1 | 2006 | 1127 | 0.040 |
Why?
|
Cell Membrane | 3 | 2005 | 3748 | 0.040 |
Why?
|
Sampling Studies | 1 | 2020 | 623 | 0.040 |
Why?
|
Peritoneal Dialysis | 1 | 2020 | 146 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 359 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1090 | 0.040 |
Why?
|
Government Programs | 1 | 2020 | 275 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2021 | 723 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2020 | 283 | 0.040 |
Why?
|
Technology | 1 | 2020 | 305 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2021 | 488 | 0.040 |
Why?
|
Green Fluorescent Proteins | 3 | 2011 | 2088 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.040 |
Why?
|
Standard of Care | 1 | 2021 | 564 | 0.040 |
Why?
|
Heart Sounds | 1 | 2016 | 20 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 850 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2006 | 2839 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2007 | 13815 | 0.040 |
Why?
|
Anthropometry | 1 | 2021 | 1350 | 0.030 |
Why?
|
Osmosis | 2 | 2007 | 113 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 681 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2007 | 18111 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5179 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2023 | 1695 | 0.030 |
Why?
|
Prolapse | 1 | 2014 | 68 | 0.030 |
Why?
|
Kinetics | 1 | 2003 | 6473 | 0.030 |
Why?
|
Microscopy, Fluorescence | 3 | 2011 | 2699 | 0.030 |
Why?
|
Gestational Age | 1 | 2023 | 3493 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9648 | 0.030 |
Why?
|
Income | 1 | 2022 | 1913 | 0.030 |
Why?
|
Blotting, Northern | 2 | 2005 | 1581 | 0.030 |
Why?
|
Thoracotomy | 1 | 2014 | 363 | 0.030 |
Why?
|
Protein Transport | 2 | 2011 | 1988 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3558 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2917 | 0.030 |
Why?
|
Transcription Factors | 1 | 2011 | 12208 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2020 | 694 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3582 | 0.020 |
Why?
|
Electron Microscope Tomography | 1 | 2010 | 18 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2020 | 1786 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9583 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2007 | 7880 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35421 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2011 | 246 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4397 | 0.020 |
Why?
|
Fetus | 1 | 2016 | 1880 | 0.020 |
Why?
|
Antiporters | 1 | 2010 | 277 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 3846 | 0.020 |
Why?
|
Plants | 1 | 2010 | 316 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 528 | 0.020 |
Why?
|
Cohort Studies | 1 | 2011 | 40561 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 12804 | 0.020 |
Why?
|
Sequence Homology | 1 | 2007 | 203 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3407 | 0.020 |
Why?
|
Phylogeny | 2 | 2005 | 2803 | 0.020 |
Why?
|
Cosmids | 1 | 2006 | 107 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2006 | 223 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2006 | 562 | 0.020 |
Why?
|
Fatigue | 1 | 2013 | 1531 | 0.020 |
Why?
|
Ion Pumps | 1 | 2005 | 15 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6442 | 0.020 |
Why?
|
Factor V | 1 | 2006 | 178 | 0.020 |
Why?
|
Ubiquinone | 1 | 2006 | 188 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5102 | 0.020 |
Why?
|
Microscopy | 1 | 2010 | 903 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2020 | 4245 | 0.020 |
Why?
|
Sodium | 1 | 2010 | 1623 | 0.020 |
Why?
|
Asparagine | 1 | 2004 | 122 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2005 | 390 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 803 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 20947 | 0.010 |
Why?
|
Erythrocytes | 1 | 2013 | 2455 | 0.010 |
Why?
|
Glycerol | 1 | 2004 | 278 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 598 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 2006 | 610 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 520 | 0.010 |
Why?
|
Proline | 1 | 2004 | 458 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2006 | 1801 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 572 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1723 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1801 | 0.010 |
Why?
|
Hydrolysis | 1 | 2002 | 682 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2004 | 853 | 0.010 |
Why?
|
Proteome | 1 | 2011 | 1799 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1682 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1213 | 0.010 |
Why?
|
Lipoproteins | 1 | 2006 | 878 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 957 | 0.010 |
Why?
|
Oocytes | 1 | 2004 | 1187 | 0.010 |
Why?
|
Biological Evolution | 1 | 2005 | 1076 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2307 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5892 | 0.010 |
Why?
|
Blood Platelets | 1 | 2006 | 2508 | 0.010 |
Why?
|
Wound Healing | 1 | 2006 | 2785 | 0.010 |
Why?
|
Escherichia coli | 1 | 2006 | 4217 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 1888 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
Mitochondria | 1 | 2006 | 3520 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2752 | 0.010 |
Why?
|
Time Factors | 2 | 2006 | 40075 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4803 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3340 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 19905 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4409 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11366 | 0.010 |
Why?
|
Anticoagulants | 1 | 2006 | 4599 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81183 | 0.000 |
Why?
|